Furthermore, eligible patients were more frequently insulin-treated, possibly due to their poorer metabolic control (p = 0.03), and had a significantly lower prevalence of advanced heart failure, end-stage renal disease and mental or psychiatric disorders compared to NE patients (p < 0.05 for all). Here, INS is linked to stage 5 chronic kidney disease.